M8 Pharmaceuticals Overview

  • Founded
  • 2007

Founded
  • Status
  • Private

  • Employees
  • 301

Employees
  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 5

M8 Pharmaceuticals General Information

Description

Provider of specialty pharmaceutical services intended to focus on the commercialization of innovative and established therapeutics in Latin American markets. The company's services are provided by partnering with pharmaceutical companies looking to establish, maintain or expand their business presence due to their understanding of the regulatory complexities, stringent quality assurance and adherence to international standards, enabling people to get innovative and proven therapies.

Contact Information

Formerly Known As
Moksha8 Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Services
Primary Office
  • 1055 Westlakes Drive
  • Suite 300
  • Berwyn, PA 19312
  • United States
+1 (610) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

M8 Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Secondary Transaction - Private 00000 Completed Generating Revenue
11. Mezzanine 15-Feb-2019 0000 00000 Completed Generating Revenue
10. Later Stage VC 06-Jan-2014 00000 Cancelled Generating Revenue
9. Later Stage VC (Series 3) 01-Nov-2012 0000 00000 Completed Generating Revenue
8. Secondary Transaction - Private 22-Oct-2012 000.00 00000 Completed Generating Revenue
7. Later Stage VC (Series C) 14-Oct-2010 0000 00000 00000 Completed Startup
6. Early Stage VC 10-Jun-2010 00.00 000.00 Completed Startup
5. Early Stage VC (Series B) 01-Dec-2009 000.00 000.00 000.00 Completed Startup
4. Early Stage VC 05-Nov-2009 $5M $50.9M Completed Startup
3. Early Stage VC 11-Feb-2009 $6.86M $45.9M Completed Startup
To view M8 Pharmaceuticals’s complete valuation and funding history, request access »

M8 Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series 3a 00,000,000 00.000000 0.00 00.0 00.0 00.0 00.000
Series 3a 00,000,000 00.000000 0.00 00.00 00.00 00.00 0.000
Series 2 00,000,000 00.000000 0.00 00.00 00.00 00.00 00.000
Series 1a 1,858,968 $0.001000 9.5% $3.29 $3.29 $3.29 1.25%
Series 1 18,706,466 $0.001000 9.5% $0.9 $0.9 $0.9 12.59%
To view M8 Pharmaceuticals’s complete cap table history, request access »

M8 Pharmaceuticals Executive Team (17)

Name Title Board Seat Contact Info
Joel Barlan Chief Executive Officer & Board Member
Rogelio Sandoval Chief Financial Officer
Saulo Xavier Chief Compliance Officer
Rafael Ferrer Vice President of corporate development
Stig Pedersen Executive Chairman
You’re viewing 5 of 17 executive team members. Get the full list »

M8 Pharmaceuticals Board Members (12)

Name Representing Role Since
Arthur Higgins Self Board Member 000 0000
Daniel Turner III Montreux Equity Partners Board Member 000 0000
Joel Barlan M8 Pharmaceuticals Chief Executive Officer & Board Member 000 0000
Mariano García-Valiño Self Board Member 000 0000
Stig Pedersen Self Executive Chairman 000 0000
You’re viewing 5 of 12 board members. Get the full list »

M8 Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

M8 Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
TPG Biotechnology Partners Other Minority 000 0000 000000 0
Montreux Equity Partners Growth/Expansion Minority 000 0000 000000 0
Aragen Life Sciences PE-Backed Company Minority 000 0000 000000 0
Lit Tele Corporation Minority 000 0000 000000 0
TPG PE/Buyout Minority 000 0000 000000 0
To view M8 Pharmaceuticals’s complete investors history, request access »